Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the seven ratings firms that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating and six have assigned a buy rating to the company. The average 1 year […]
Analysts Set Sangamo Therapeutics, Inc (NASDAQ:SGMO) Target Price at $5 80 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
CAMBRIDGE, Mass., Sept. 25, 2023 Voyager Therapeutics, Inc. , a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced that Chief Executive.
StockNews.com upgraded shares of Sangamo Therapeutics (NASDAQ:SGMO – Free Report) to a sell rating in a report published on Wednesday morning. A number of other brokerages have also recently commented on SGMO. HC Wainwright reiterated a buy rating and set a $5.00 target price on shares of Sangamo Therapeutics in a report on Monday, August […]
Beam Therapeutics (NASDAQ:BEAM – Get Free Report) and Biogen (NASDAQ:BIIB – Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, valuation, profitability and analyst recommendations. Earnings & Valuation This table compares Beam Therapeutics and […]